Target Gene/Pathway(薬物標的遺伝子/パスウェイリスト)
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z other
No. | KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * | KEGG DRUG * | DrugBank | 指定難病告示番号 * |
1 | Aldosterone synthesis and secretion |
1件: MC2R | D00284 | Tetracosactide | 5件: 78, 83, 113, 145, 222 |
2 | Breast cancer |
2件: ESR1, ESR2 | D08409 | Prasterone | 6件: 49, 53, 83, 86, 96, 113 |
3 | cAMP signaling pathway |
1件: MC2R | D00284 | Tetracosactide | 5件: 78, 83, 113, 145, 222 |
4 | Cortisol synthesis and secretion |
1件: MC2R | D00284 | Tetracosactide | 5件: 78, 83, 113, 145, 222 |
5 | Cushing syndrome |
1件: MC2R | D00284 | Tetracosactide | 5件: 78, 83, 113, 145, 222 |
6 | Endocrine and other factor-regulated calcium reabsorption |
1件: ESR1 | D08409 | Prasterone | 6件: 49, 53, 83, 86, 96, 113 |
7 | Endocrine resistance |
2件: ESR1, ESR2 | D08409 | Prasterone | 6件: 49, 53, 83, 86, 96, 113 |
8 | Estrogen signaling pathway |
2件: ESR1, ESR2 | D08409 | Prasterone | 6件: 49, 53, 83, 86, 96, 113 |
9 | GnRH secretion |
1件: ESR2 | D08409 | Prasterone | 6件: 49, 53, 83, 86, 96, 113 |
10 | Hematopoietic cell lineage |
1件: MS4A1 | D02994 | Rituximab | 42件: 11, 13, 14, 17, 35, 36, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 223, 229, 256, 271, 283, 284, 285, 288, 300, 331 |
11 | Neuroactive ligand-receptor interaction |
1件: MC2R | D00284 | Tetracosactide | 5件: 78, 83, 113, 145, 222 |
1件: NR3C1 | D00292 | Dexamethasone | 20件: 13, 16, 28, 35, 46, 53, 63, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 222, 296, 299 | ||
D00975 | |||||
D01510 | |||||
D01615 | |||||
D01632 | |||||
D01948 | |||||
D02174 | |||||
D02591 | |||||
D02592 | |||||
D00088 | Hydrocortisone | 8件: 6, 53, 75, 78, 81, 83, 97, 299 | |||
D00165 | Hydrocortisone acetate | 8件: 6, 53, 75, 78, 81, 83, 97, 299 | |||
D00976 | Hydrocortisone cypionate | 2件: 81, 83 | |||
D01442 | Hydrocortisone succinate | 3件: 6, 81, 83 | |||
D00407 | Methylprednisolone | 36件: 2, 13, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 145, 164, 220, 222, 224, 271, 283, 284, 285, 296 | |||
D00751 | |||||
D00979 | |||||
D05000 | |||||
D05001 | |||||
D05002 | |||||
12 | Oocyte meiosis |
1件: AR | D08409 | Prasterone | 6件: 49, 53, 83, 86, 96, 113 |
13 | Pathways in cancer |
3件: AR, ESR1, ESR2 | D08409 | Prasterone | 6件: 49, 53, 83, 86, 96, 113 |
14 | Prolactin signaling pathway |
2件: ESR1, ESR2 | D08409 | Prasterone | 6件: 49, 53, 83, 86, 96, 113 |
15 | Prostate cancer |
1件: AR | D08409 | Prasterone | 6件: 49, 53, 83, 86, 96, 113 |
16 | Proteoglycans in cancer |
1件: ESR1 | D08409 | Prasterone | 6件: 49, 53, 83, 86, 96, 113 |
17 | Thyroid hormone signaling pathway |
1件: ESR1 | D08409 | Prasterone | 6件: 49, 53, 83, 86, 96, 113 |